News from Cancer Discovery

• Avapritinib Approved for GIST Subgroup
  Drug is “super-potent” against gastrointestinal stromal tumors harboring rare driver mutation.
• Free Article | Q&A: Christina Curtis on Computational and Systems Biology
  Novel technologies and modeling approaches are helping researchers quantify the biology of tumors.
• Pediatric Cancer Survivorship Portal Released
  Datasets from St. Jude and other organizations can be visualized and analyzed on cloud-based platform.